Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut

Cristiano G Moreira; Regan Russell; Animesh Anand Mishra; Sanjeev Narayanan; Jennifer M Ritchie; Matthew K Waldor; Meredith M Curtis; Sebastian E Winter; David Weinshenker; Vanessa Sperandio

doi:10.1128/mBio.00826-16

. 2016 Jun 7;7(3):e00826-16. doi: 10.1128/mBio.00826-16

Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut

Cristiano G Moreira ^a,^b,^c, Regan Russell ^a,^b, Animesh Anand Mishra ^a,^b, Sanjeev Narayanan ^d, Jennifer M Ritchie ^e, Matthew K Waldor ^f, Meredith M Curtis ^a,^b, Sebastian E Winter ^a, David Weinshenker ^g, Vanessa Sperandio ^a,^b,^✉

PMCID: PMC4959670 PMID: 27273829

ABSTRACT

Enteric pathogens such as enterohemorrhagic Escherichia coli (EHEC) and Citrobacter rodentium, which is largely used as a surrogate EHEC model for murine infections, are exposed to several host neurotransmitters in the gut. An important chemical exchange within the gut involves the neurotransmitters epinephrine and/or norepinephrine, extensively reported to increase virulence gene expression in EHEC, acting through two bacterial adrenergic sensors: QseC and QseE. However, EHEC is unable to establish itself and cause its hallmark lesions, attaching and effacing (AE) lesions, on murine enterocytes. To address the role of these neurotransmitters during enteric infection, we employed C. rodentium. Both EHEC and C. rodentium harbor the locus of enterocyte effacement (LEE) that is necessary for AE lesion formation. Here we show that expression of the LEE, as well as that of other virulence genes in C. rodentium, is also activated by epinephrine and/or norepinephrine. Both QseC and QseE are required for LEE gene activation in C. rodentium, and the qseC and qseE mutants are attenuated for murine infection. C. rodentium has a decreased ability to colonize dopamine β-hydroxylase knockout (Dbh^−/−) mice, which do not produce epinephrine and norepinephrine. Both adrenergic sensors are required for C. rodentium to sense these neurotransmitters and activate the LEE genes during infection. These data indicate that epinephrine and norepinephrine are sensed by bacterial adrenergic receptors during enteric infection to promote activation of their virulence repertoire. This is the first report of the role of these neurotransmitters during mammalian gastrointestinal (GI) infection by a noninvasive pathogen.

IMPORTANCE

The epinephrine and norepinephrine neurotransmitters play important roles in gut physiology and motility. Of note, epinephrine and norepinephrine play a central role in stress responses in mammals, and stress has profound effects on GI function. Bacterial enteric pathogens exploit these neurotransmitters as signals to coordinate the regulation of their virulence genes. The bacterial QseC and QseE adrenergic sensors are at the center of this regulatory cascade. C. rodentium is a noninvasive murine pathogen with a colonization mechanism similar to that of EHEC, enabling the investigation of host signals in mice. The presence of these neurotransmitters in the gut is necessary for C. rodentium to fully activate its virulence program, in a QseC/QseE-dependent manner, to successfully colonize its murine host. Our study data provide the first example of epinephrine and norepinephrine signaling within the gut to stimulate infection by a bacterial pathogen in a natural animal infection.

INTRODUCTION

The survival of an organism is dependent on its intrinsic ability to detect and efficiently respond to stress cues. The neurotransmitters epinephrine (Epi) and norepinephrine (NE) play a central role in stress responses in mammals. Notably, stress affects gastrointestinal (GI) function, leading to increased gastric acid production and intestinal motility, and can also alter the composition of the gut microbiota (1). Both epinephrine and norepinephrine have important biological roles in the human GI tract. Norepinephrine is synthesized locally within the enteric nervous system (ENS) by adrenergic neurons in the basal-lateral layer of the gut (2). Epinephrine is mostly synthesized in the adrenal medulla but can reach the gut through the bloodstream (3). These neurotransmitters play important GI functions, modulating intestinal smooth muscle contraction, submucosal blood flow, and chloride and potassium secretion (4). There is an important relationship between the gut microbiota and the availability of active epinephrine and/or norepinephrine in the lumen. These neurotransmitters are inactivated by the host by glucuronidation, and the GI microbiota encodes glucuronidases that deconjugate glucuronic acid from epinephrine and norepinephrine, increasing the levels of these biologically active neurotransmitters in the lumen (5).

Moreover, epinephrine and/or norepinephrine have direct effects on bacterial physiology and virulence gene expression through interaction with the bacterial adrenergic receptors QseC and QseE (see Fig. 3A) (6 –24). The role of epinephrine and/or norepinephrine in stimulating virulence gene expression has been extensively studied in the human enteric pathogen enterohemorrhagic Escherichia coli (EHEC) (11, 19 –21, 23, 25, 26). EHEC is a foodborne pathogen responsible for major outbreaks of bloody diarrhea and hemolytic uremic syndrome (HUS) worldwide (27). EHEC colonizes the colon, where it forms attaching and effacing (AE) lesions on enterocytes. The locus of enterocyte effacement (LEE) pathogenicity island contains most of the genes necessary for AE lesion formation. The LEE contains 41 genes, the majority of which are organized within five major operons: LEE1 to LEE5 (28 –30). The LEE genes encode a type III secretion system (T3SS) (31), an adhesin (intimin) (32) and its receptor (Tir) (33), and transcriptional regulators, chaperones, and effector proteins (34 –38). EHEC senses the host neurotransmitters epinephrine and/or norepinephrine through QseC and QseE, thereby relaying notification of the presence of these chemical signals to a complex regulatory cascade and leading to transcription of key virulence genes. QseC is at the top of this signaling cascade, and, upon sensing epinephrine, it activates expression of the qseEF genes. In addition to genetic regulation between these two systems, there is also cross talk at the phosphorylation level. QseC phosphorylates three response regulators (RRs), its cognate RR QseB, KdpE, and QseF. QseE, however, exclusively phosphorylates QseF. This signaling cascade operating via QseC directly activates transcription of the LEE through KdpE. LEE transcriptional expression is indirectly controlled through QseEF. QseEF repress expression of rcsB, which encodes an RR that also activates LEE transcription. Hence, the increased expression of rcsB in a qseE mutant leads to increased LEE expression (11, 19 –21, 23 –26). These transcription events ultimately enable the organism to form AE lesions and produce Shiga toxin (responsible for HUS), thereby leading to the clinical manifestations of infection (7, 19, 20, 23).

FIG 3 — Virulence gene regulation in *C. rodentium* by epinephrine and norepinephrine. (A) Scheme of recognition by the QseC and QseE bacterial adrenergic receptors of their signals. QseC senses epinephrine (Epi) and norepinephrine (NE), and QseE senses Epi, NE, sulfate (SO₄), and phosphate (PO₄). (B) Homology comparisons among the LEE regions of EHEC, enteropathogenic *E. coli* (EPEC), and *C. rodentium*. (C) Expression of genes within the QseC regulon, the LEE, effectors, and adhesins in the absence and presence of 50 µM epinephrine or norepinephrine in DMEM (OD₆₀₀ of 0.7 at 37°C).

However, studies of the role of these neurotransmitters in EHEC virulence during mammalian infection have been lacking because EHEC does not form AE lesions on the intestine of mice, and studies of the EHEC-host relationship at the level of intestinal disease have had to rely on expensive and genetically intractable animal models. A variety of other animal species, including mice, gnotobiotic piglets, baboons, ferrets, and calves, have been used as models to study the virulence of EHEC (39 –48). EHEC is able to colonize streptomycin-treated mice; however, it does not cause AE lesions in these animals and its toxicity in this model is solely due to Shiga toxin (44, 45), given that these results could be reproduced using an E. coli K-12 strain carrying cloned stx genes (encoding Shiga toxin) (45). Ferrets (streptomycin treated) were also evaluated as a possible small-animal model for EHEC infection (46). These animals developed hematuria and /or histological damage of glomeruli or thombocytopenia, but there was no evidence of colitis or AE lesion formation in intestinal epithelial cells. Thus, the ferret and the streptomycin-treated mouse models may serve as models for renal disease secondary to intestinal infection with EHEC. EHEC is able to cause AE lesions in large animals such as suckling neonatal piglets (42) and neonatal calves (39). However, these animals are expensive and difficult to manage for screening large numbers of potential virulence genes. Finally, the nonhuman primate animal models (baboons) are limited by the high cost. In the infant rabbit animal model, EHEC colonizes the large intestine, forming AE lesions and causing diarrhea (49, 50), but, unlike murine models, rabbits are genetically intractable, hampering studies assessing the host genetic contribution to EHEC intestinal infection. An alternative used by many investigators in the field is to study Citrobacter rodentium as a surrogate for EHEC. This natural murine pathogen, like EHEC, harbors the LEE (see Fig. 3B) and forms AE lesions on the intestine of mice, leading to colonic hyperplasia (51, 52). All of the known virulence genes of EHEC have been validated in vivo using C. rodentium murine infections (52 –56). The utilization of the C. rodentium model capitalizes on merging the powerful genetically tractability of host and pathogen to unravel the mechanisms involved in host recognition and infection. Here we employed EHEC and C. rodentium animal models to investigate the role of epinephrine/norepinephrine and the bacterial adrenergic receptors QseC and QseE in the pathogenesis of noninvasive enteric pathogens.

RESULTS

The role of QseC and QseE in mammalian infections.

The most suitable small-animal model for EHEC is the infant rabbit model, where EHEC colonizes the colon of these animals, forming AE lesions and causing disease. The proficiency of EHEC to colonize the intestine of these mice correlates with the severity of disease; hence, the assessment of CFUs of EHEC in the intestine of these animals provides a numeric readout of disease (49, 50). Using this infection model, we have previously shown that an EHEC qseC mutant is attenuated, with a decreased ability to colonize the colon, ileum, and cecum of these animals on day 5 (D5) postinfection (7). However, we did not know the contribution of the QseE adrenergic sensor for EHEC infection of infant rabbits. Moreover, we also have not investigated the pathogenicity of a double-sensor mutant. We have now assessed pathogenesis of EHEC qseE and qseEC mutants using this model. The qseE mutant initially (day 2 postinfection) colonizes the ileum and colon of these animals to higher levels than the wild type (WT) (Fig. 1) and later during infection (day 5) behaves similarly to the WT (Fig. 2). This initial higher colonization by the qseE mutant is congruent with the overexpression of the LEE genes (24). We have previously reported that, although qseC and qseE individual mutants can still sense epinephrine and norepinephrine to regulate certain arms of this signaling cascade, an EHEC qseEC mutant is unable to sense these neurotransmitters (24). The EHEC qseEC mutant presents decreased colonization of the ileum on day 2 postinfection (Fig. 1) and decreased colonization of the ileum, cecum, and colon and less bacteria within the stool at day 5 compared to the WT (Fig. 2), having a phenotype that mirrors that of the EHEC qseC mutant during infection of infant rabbits (7). This is not a surprising result, because QseC activates expression of the qseEF genes, being at the top of this signaling cascade (57). These data suggest that the ability to sense epinephrine and norepinephrine through both the QseC and QseE sensors promotes EHEC’s virulence during mammalian infection.

FIG 1 — EHEC infection in infant rabbits at day 2 postinfection. Data depict CFUs of EHEC in the ileum (A), cecum (B), colon (C), and stool (D). *, P < 0.05; ***, P < 0.001.

FIG 2 — EHEC infection in infant rabbits at day 5 postinfection. Data depict CFUs of EHEC in the ileum (A), cecum (B), colon (C), and stool (D). **, P < 0.01; ***, P < 0.001.

Epinephrine and norepinephrine regulate virulence gene expression in C. rodentium.

One limitation of the infant rabbit model is the inability to generate knockout animals to assess the role of the host genetic repertoire in pathogen-host associations. To address this limitation, we employed the C. rodentium murine infection model. C. rodentium has the LEE genes (Fig. 3B) and colonizes and forms AE lesions in the colon (51, 52), which is the same GI site colonized by EHEC (58). Importantly, C. rodentium harbors the QseC and QseE adrenergic sensors. Both epinephrine and norepinephrine increased expression of virulence genes in C. rodentium, including the LEE genes (which encode a T3SS essential for intestinal colonization, colonic hyperplasia, and pathogenesis [52]), several effector genes (nleA and nleB), adhesin genes, and many genes within the QseC and QseE regulatory cascade (Fig. 3C; see also Fig. S2 in the supplemental material).

QseC and QseE are involved in LEE and nleA gene regulation in EHEC, with QseC activating their expression, while QseE represses it (24). Similarly to EHEC, QseC also activates expression of the LEE and nleA genes in C. rodentium (see Fig. S1 and S2 in the supplemental material). However, QseE has a contrasting function in C. rodentium; while it represses expression of the LEE and nleA genes in EHEC, it activates expression of these genes in C. rodentium (see Fig. S1 and S2). It is worth noting that, while QseC LEE and nleA gene regulation occurs directly by the activity of the QseC-phosphorylated response regulator KdpE in conjunction with Cra (59), activating expression of ler (59), which encodes the direct transcription activator of the LEE and nleA genes (29, 60), QseE regulation is indirectly controlled through the RcsB system (24). Moreover, QseE’s regulation also occurs posttranscriptionally, with QseE’s response regulator QseF activating expression of the GlmY small RNA (sRNA), which plays a role in the stability of the LEE4 and LEE5 operons and the nleA transcript (61, 62). Although the LEE is present in both EHEC and C. rodentium, several genes within the LEE4 and LEE5 operons have sequences that diverge between these two species (Fig. 3B), which could account for this differential regulation. Importantly, both QseC and QseE are involved in sensing epinephrine, with the qseC and qseE mutants being unable to activate the expression of the LEE and nleA genes in response to this signal (see Fig. S2 in the supplemental material).

QseC and QseE are necessary for LEE gene activation in C. rodentium (see Fig. S1 and S2 in the supplemental material), and we have previously published results showing that qseC, cra, and kdpE C. rodentium mutants are attenuated for murine infection using high infectious doses of 10⁹ CFU (63, 64) and employing susceptible C3H-HeJ animals that succumb to death upon C. rodentium infection (65). Here we first refined these studies using different infectious doses to gain a full understanding of the attenuation of the qseC mutant. All experiments were performed with doses of 10⁵, 10⁸, and 10⁹ CFU using 10 mice per group (Fig. 4A to C). The WT-infected animals all succumbed to death eventually, with the lower infectious doses prolonging the time to death. The qseC mutant was attenuated compared to the WT results at all infectious doses, and at the lowest infectious dose (10⁵), all of the animals infected with the qseC mutant survived, while all animals infected with the WT strain succumbed to death (Fig. 4C). We also tested the C. rodentium qseE mutant for murine infection using an infectious dose of 10⁹ CFU. Death of ΔqseE mutant-infected animals was delayed by 1 day compared to the WT results, a difference which is statistically significant (P < 0.02) (Fig. 4D). The colon weights of ΔqseE mutant-infected animals (a readout of colonic hyperplasia) were lower than the weights measured for animals infected with the WT strain, being similar to those seen with the control animals administered phosphate-buffered saline (PBS) (Fig. 4E). Of note, we have previously published that the colon weight of ΔqseC mutant-infected animals was also lower than that of WT-infected animals (63). Taken together, these data indicate that both the qseC and qseE C. rodentium mutants are attenuated for murine infection, in accordance with the role of these two sensors in activating expression of the virulence genes (see Fig. S1 and S2).

FIG 4 — *C. rodentium* murine infections in C3H/HeJ mice. (A) Survival curves of animals infected with different doses of the WT strain and the *qseC* mutant with an infectious dose of 10⁹ CFU. (B) Survival curves of animals infected with different doses of the WT strain and the *qseC* mutant with an infectious dose of 10⁸ CFU. (C) Survival curves of animals infected with different doses of the WT strain and the *qseC* mutant with an infectious dose of 10⁵ CFU. (D) Survival curves of animals infected with the WT strain and the *qseE* mutant (P < 0.02). (E) Colon weights of animals infected with the WT strain and the *qseE* mutant; PBS is the negative control.

Epinephrine and norepinephrine are required for full virulence of C. rodentium during mammalian infection.

Norepinephrine is synthesized from dopamine by the enzyme dopamine β-hydroxylase (Dbh), and phenylethanolamine-N-methyl transferase (PNMT) synthesizes epinephrine from norepinephrine. To investigate the role of epinephrine and norepinephrine in C. rodentium infection, we devised experiments using Dbh knockout animals (Dbh^−/−). These experiments were performed using Dbh^+/− mice (the heterozygous mice are known to behave as WT for production of epinephrine and norepinephrine and represent the parent strain for the knockout animals), and the Dbh^−/− mice (which do not produce any epinephrine or norepinephrine) (66). However, these mouse strains are derived from a mix of C57BL6/J and 129x1/SvEv mice, which are more resistant to C. rodentium infection than C3H-HeJ mice. 129x1/SvJ mice are colonized at high numbers by C. rodentium and develop colonic hyperplasia and inflammation and compromised crypt integrity and also lose goblet cells, similarly to the results of C. rodentium infection of C3H-HeJ. However, unlike C3H-HeJ mice, 129x1/SvJ mice resolve and survive infection (65). Our pilot studies with 129x1/SvJ animals also confirmed that they develop disease and are colonized by C. rodentium but do not die (see Fig. S3 in the supplemental material). Hence, we decided not to perform survival studies in the Dbh^+/− and Dbh^−/− animals and to focus on other parameters of C. rodentium-mediated disease. In these resistant C. rodentium murine infection models, colonization of the intestine (CFU counts) correlates with the severity of the disease (65). These animals were infected with 1 × 10⁹ CFU of the C. rodentium WT strain and of the qseC, qseE, and qseEC mutants. We monitored CFU, LEE gene expression, and the composition of the microbiota in their stools during infection (Fig. 5, 6, and 7). We also performed comprehensive pathology analyses of their colons (Table 1). The animals were sacrificed on day 7, which, in this strain of mice, in our hands, corresponds to the peak of disease.

FIG 5 — Microbiota composition of *Dbh^+/−* and *Dbh^−/−* mice infected with WT, Δ*qseC*, Δ*qseE*, and Δ*qseEC C. rodentium* at day 1 (A) and day 7 (B) postinfection. PBS mice were used as negative controls.

FIG 6 — CFUs in stools of *Dbh^+/−* and *Dbh^−/−* mice infected with WT, Δ*qseC*, Δ*qseE*, and Δ*qseEC C. rodentium* on days 1 to 7. PBS mice were used as negative controls. *, P < 0.0001.

FIG 7 — Expression of the LEE *espA* and *tir* genes, measured by qRT-PCR, in stools of Dbh^+/− and Dbh^−/− mice infected with WT, Δ*qseC*, Δ*qseE*, and Δ*qseEC C. rodentium* on day 7 postinfection. PBS mice were used as negative controls. *, P < 0.05; **, P < 0.0001.

TABLE 1 .

Pathology scoring of large intestine

Sample	Score
Sample	Edema^a	Crypt integrity^b	Lymphocyte^c	Neutrophil^d	Apoptosis^e	Vasculitis^f
PBS Dbh^+/−	0	0	0	0	0	0
WT Dbh^+/−	2	2	3	1	4–8	3
ΔqseC Dbh^+/−	0	0	1	0	0	0
ΔqseE Dbh^+/−	0	0	4	0	1–2	1
ΔqseEC Dbh^+/−	1	0	4–6	1	1–2	1
PBS Dbh^−/−	0	0	4	0	0	0
WT Dbh^−/−	3	4	6–10	4	6–8	1
ΔqseC Dbh^−/−	1.5	2	5–6	6	5	1
ΔqseE Dbh^+/−	0	2	5–6	4	2	0
ΔqseEC Dbh^+/−	0	0	3	0	2	0

Open in a new tab

Scores for (submucosal) edema are 0 for no edema and 5 for the highest edema in the submucosa.

Scores for crypt integrity are 0 for normal crypts, 1 for irregular crypts, 2 for mild crypt loss, 3 for severe crypt loss, and 4 for complete crypt loss.

Scores for lymphocytes represent the actual numbers of lymphocytes in the lamina propria (between adjacent crypts).

Scores for neutrophilic infiltration in the wall (mainly perivascular in the submucosa but also seen occasionally in the lamina propria and the lumen) are 0 for no infiltration and 6 for the highest infiltration.

Scores for apoptosis represent the number of apoptotic cells per ×600 field (five fields were counted). Numbers of apoptotic cells occasionally differed in areas of greater severity versus lesser severity; those instances are represented by two numbers.

Scores for vasculitis are 0 for no evidence of vasculitis and 5 for the most severe vasculitis (i.e., loss of vessel wall architecture due to infiltration on leukocytes, presence of nuclear debris, and exudation of eosinophilic proteinaceous material; this is called leukocytoclastic vasculitis/fibrinoid necrosis in pathology literature). All of these changes are statistically significant (P < 0.05).

There are no previous reports on whether the presence or absence of epinephrine and norepinephrine affects the composition of the gut microbiota. Because the virulence and infectivity of EHEC and C. rodentium are altered by the microbiota (64, 67 –69) and because the microbiota plays an important role in the availability of active epinephrine and/or norepinephrine in the lumen (5), we investigated the compositions of the microbiotas of uninfected and infected Dbh^+/− and Dbh^−/− animals at the phylum level. The compositions were similar on day 1 of C. rodentium infection (Fig. 5A). At day 7, the uninfected animals had microbiotas that were similar to those of each other and to their microbiotas prior to infection (Fig. 5B). Infection of Dbh^+/− and Dbh^−/− mice resulted in changes in the microbiota with all strains. However, these changes differed depending on whether these animals were or were not able to produce epinephrine and norepinephrine. At day 7, in animals infected with WT C. rodentium, the microbiota composition was dominated by γ-proteobacteria in both strains of mice, but the Dbh^−/− animals had more Firmicutes than the Dbh^+/− animals, and the Dbh^+/− animals had more Bacteroidetes. At day 7 postinfection, the ΔqseC mutant-infected animals also had their microbiota dominated by γ-proteobacteria in both strains of mice but to a lesser degree than the animals infected with the WT strain. The animals infected with the ΔqseC mutant showed an enhancement of Bacteroidetes and Firmicutes populations compared to WT-infected animals but kept the same pattern of the Dbh^+/− mice being enriched for Bacteroidetes, while the Dbh^−/− mice were enriched for Firmicutes. At day 7 postinfection, the ΔqseE mutant-infected animals had similar microbiota profiles in the Dbh^+/− and Dbh^−/− strains of mice. However, compared to WT-infected animals, ΔqseE mutant-infected animals had even more γ-proteobacteria and fewer Bacteroidetes and no Firmicutes. The most striking microbiota differences between Dbh^+/− and Dbh^−/− mice occurred at day 7 in animals infected with the double qseEC mutant. The microbiota of the ΔqseEC mutant-infected Dbh^+/− mice was dominated by Firmicutes, in contrast to animals infected with the WT strain, and presented the least prevalence of γ-proteobacteria. The microbiota of the ΔqseEC mutant-infected Dbh^−/− mice was very similar to the microbiota of the mice infected with the WT strain, with a prevalence of γ-proteobacteria and few Bacteroidetes and more Firmicutes in relation to Bacteroidetes (Fig. 5B). These studies suggest that the GI microbiotas are similar in the absence and presence of epinephrine and norepinephrine but that a C. rodentium infection has different impacts with respect to the changes that occur in the microbiota in the absence and presence of these hormones. Moreover, whether C. rodentium can sense these hormones also differentially impacts the composition of the microbiota in Dbh^+/− and Dbh^−/− animals. The observation that the microbiotas of Dbh^+/− and Dbh^−/− mice infected with the ΔqseEC mutant also differ suggests that there may be still another epinephrine/norepinephrine sensory mechanism in EHEC in addition to QseC and QseE. A third epinephrine/norepinephrine sensor has been suggested to exist in Salmonella enterica (70).

The levels of colonization differed dramatically when WT C. rodentium was used to infect Dbh^+/− versus Dbh^−/− mice. Throughout the infection, WT C. rodentium colonized Dbh^+/− animals to higher levels than the Dbh^−/− mice (differences of between 2 and 3 logs), suggesting that epinephrine and norepinephrine profoundly alter infection in vivo (Fig. 6). Colonization of the qseC, qseE, and qseEC mutants in the Dbh^+/− mice was decreased compared to the WT strain (Fig. 6), indicating that QseC and QseE promote colonization during infection. The difference in colonization of Dbh^+/− versus Dbh^−/− mice by any given strain was largely lost in the infections by the qseC, qseE, and qseEC mutants (Fig. 6), suggesting that differences in colonization upon infection of Dbh^+/− versus Dbh^−/− mice depend on both QseC and QseE, and indicating that both of these sensors are required to distinguish an intestine with epinephrine and norepinephrine from one without and to better colonize the former.

Expression of the LEE genes in WT C. rodentium was decreased in the Dbh^−/− animals compared to the Dbh^+/− animals, indicating that C. rodentium senses epinephrine and norepinephrine in vivo (Fig. 7). These data suggest that the absence of the host epinephrine and norepinephrine hormones in the Dbh^−/− mice prevents C. rodentium from optimally activating LEE gene expression, leading to decreased gut colonization (Fig. 6). Moreover, LEE expression is decreased in the qseC, qseE, and qseEC mutants compared to the WT strain during infection of both Dbh^+/− and Dbh^−/− mice, which suggests that the QseC and QseE sensors function in vivo. Expression of the LEE espA and tir genes was further decreased in the Dbh^−/− mice infected with the qseC mutant compared to infection of the Dbh^+/− mice and was decreased to similar levels in the two murine strains infected with the qseE mutant. Expression of tir was decreased in the qseEC mutant compared to the WT in both murine strains, but expression of espA, albeit reduced compared to the level seen with the WT in all animals infected with the qseEC mutant, was increased in the Dbh^−/− mice compared to the Dbh^+/− animals (Fig. 7), which suggests that there is yet another manner to distinguish these animals in addition to analysis of QseC and QseE. Taken together, these data suggest that QseC and QseE are involved in C. rodentium sensing of epinephrine and norepinephrine in the gut to activate the LEE and colonize the GI tract.

Concerning intestinal pathology, uninfected Dbh^−/− animals presented more lymphocytes than Dbh^+/− animals, suggesting that epinephrine and norepinephrine play a role in preventing inflammation in the gut. Infection with WT C. rodentium led to increased edema, decreased crypt integrity, and increased inflammation in the Dbh^−/− animals compared to the Dbh^+/− animals. Although expression of the LEE and C. rodentium colonization were decreased during infection of the Dbh^−/− animals, the inherent increased inflammation in the intestine of these mice probably led to this increase in pathology, even though there was a smaller amount of pathogen, with decreased virulence. Infection with both the qseC and qseE mutants also led to increased pathology in the Dbh^−/− animals. However, infections with both mutants led to less pathology and inflammation than was seen with the WT in both the Dbh^−/− and Dbh^+/− mice (Table 1). These data suggest that although the activity of the qseC and qseE mutants was attenuated compared to that of the WT, the Dbh^−/− mice still presented more inflammation and decreased crypt integrity, even when infected with attenuated strains of C. rodentium, because of their inherent gut inflammation (66). The qseEC mutant, however, showed decreased pathology in comparison to the WT in both mouse strains and was similarly attenuated in the Dbh^+/− and Dbh^−/− mice. In fact, the pathology scores determined for the two mouse strains infected with the double mutant were largely similar to the scores determined for the uninfected (PBS-treated) animals. The qseEC mutant has both epinephrine/norepinephrine sensors deleted, suggesting that a C. rodentium strain that cannot sense these hormones is attenuated for disease and cannot even cause issues in the Dbh^−/− mice, even though they have inherent gut inflammation. It is worth considering that the QseC and QseE sensors also sense other signals in addition to epinephrine and norepinephrine. QseC senses microbiota-produced signal autoinducer-3 (AI-3) (19, 20), and QseE senses SO₄ and PO₄ (23). Hence, in addition to the absence of the adrenergic signals, the qseEC mutant is also impaired for sensing other signals that contribute to virulence gene regulation in EHEC and C. rodentium.

DISCUSSION

Epinephrine and norepinephrine exert a profound effect in the host physiology and immune system, and the ability of bacteria to sense these hormones may facilitate gauging the fitness of the host (19, 20, 71). Specifically, in the GI tract, which is one of the most prominent sites in the human body where host/microbe associations are paramount, these neurotransmitters play important functions in gut homeostasis and physiology (19, 20, 71). This two-way-street communication is currently gaining appreciation given that there are important relationships between neurotransmitters and the GI microbiota, with the microbiota inducing biosynthesis of the serotonin neurotransmitter (72) and modulating the levels of active epinephrine and norepinephrine in the gut lumen (5). Disruption of these relationships and of the structure of the bacterial communities that inhabit the gut can contribute to dysbiosis leading to disease. An important insult that causes dysbiosis is infection by an invading pathogen. It is known that invading enteric pathogens such as Salmonella enterica and C. rodentium cause inflammation within the gut that in turn diminishes the overall numbers of bacteria in the microbiota, sometimes acting as a competition advantage to the pathogen (73, 74). Additionally, infection with C. rodentium also causes significant changes in the structure of the microbial community, decreasing the number of anaerobes and increasing the numbers of γ-proteobacteria (73). C. rodentium is a murine pathogen that models enteric infection by the human pathogen EHEC, and both pathogens sense epinephrine and norepinephrine to activate their virulence genes (11, 19 –21, 23, 25, 26) (Fig. 3; see also Fig. S1 and S2 in the supplemental material).

These two neurotransmitters are sensed by the bacterial QseC and QseE sensors (20, 23). In both EHEC and C. rodentium, the qseC and qseEC mutants are attenuated for animal infections (7, 20, 63) (Fig. 2 to 4 and 6). The qseEC mutant is largely unable to detect and respond to epinephrine and/or norepinephrine (24) highlighting the important role of these neurotransmitters in enteric infection. However, the phenotypes of the qseE mutants differ between these pathogens (24) (Fig. 1 to 4 and 6; see also Fig. S1 and S2 in the supplemental material). An explanation for this difference is that QseE acts indirectly and posttranscriptionally in expression of the LEE island as well as of other effectors, such as NleA (24, 61). QseE exclusively phosphorylates its cognate response regulator (RR), QseF (75), while QseC acts through three RRs, its cognate QseB and the noncognates KdpE and QseF (21). The QseC tripartite signaling cascade activates LEE expression directly through KdpE and the gluconeogenesis sensor Cra (24). QseE acts indirectly through QseF, which directly activates expression of the glmY gene, and the GlmY sRNA mediates degradation of the LEE4 and LEE5 transcripts in EHEC (61). The homology between the LEE1, LEE2, and LEE3 operons of EHEC and C. rodentium is high; however, the sequences of LEE4 and LEE5 are very divergent (Fig. 3B), and there is consequently a high probability that they would be differentially regulated at the posttranscriptional level. In fact, posttranscriptional regulation has been reported to differ even within EHEC strains (76 –78). These data indicate that, although C. rodentium can be useful for addressing and mirroring certain aspects of EHEC pathogenesis, allowing for murine infections, one has to be cautious and aware of some of the limitations of this model. However, even with some of these limitations, the double qseEC mutant of both pathogens is attenuated for mammalian infection (Fig. 1 to 4 and 6).

The ability to harness the genetic tractability of murine models allowed us to investigate for the first time the role of epinephrine and/or norepinephrine impacting the pathogenesis of a noninvasive enteric pathogen. C. rodentium, as well as EHEC, does not breach the intestinal mucosa and invade the host systemically; the bacteria are restricted to the mucosal layer of the intestine (58, 79). It is very well established that norepinephrine is present in the basolateral layer of the intestine, where it is produced by adrenergic neurons of the enteric nervous system (2). However, whether it is present in the mucosal and luminal surface of the intestine, which is the compartment occupied by both EHEC and C. rodentium, was unresolved for many years. Recent evidence indicates that active norepinephrine is present in the lumen and mucosal layer and that the microbiota plays a key role in facilitating activation of this neurotransmitter (5). Using Dbh^−/− knockout mice that do not produce epinephrine and norepinephrine, we have now been able to show that optimal LEE expression is dependent on these neurotransmitters and is also dependent on QseC and QseE (Fig. 7), leading to decreased levels of gut colonization by C. rodentium in these knockout animals (Fig. 6).

There is a growing appreciation of the complex microbial interactions within the gut-brain axis. Recent research has been elucidating how microbes can affect host behavior, and there is also a strong link between neurological function and the gut microbiota. Neurological diseases, such as autism, depression, and neurodegenerative diseases, are often strongly influenced by intestinal factors (80). The host neurotransmitters can also influence microbial behaviors, with studies of epinephrine and norepinephrine being at the forefront of this research (71). Although most of the epinephrine/norepinephrine modification of bacterial behavior was performed using gut pathogens, we could investigate these relationships in vivo only now using genetically tractable microbial and host systems.

MATERIALS AND METHODS

Isogenic mutant construction.

Nonpolar mutants of qseE and qseEC in C. rodentium were constructed through the use of a lambda Red system (81). Briefly, PCR products were amplified from plasmid pKD3 with flanking regions matching qseE and were transformed into the C. rodentium WT or the qseC mutant (63) expressing the RED genes from plasmid pKD46. After selection and confirmation, the resistance cassette was resolved using flippase from temperature-sensitive plasmid pCP20, which was then cured through growth at 37°C. This generated nonpolar mutants which were confirmed by sequencing.

In vitro qRT-PCR.

Overnight cultures of WT (in the absence or presence of 50 µM epinephrine or norepinephrine) and ΔqseC, ΔqseE and ΔqseEC strains were diluted 1:100 and grown aerobically at 37°C in low-glucose Dulbecco’s modified Eagle medium (DMEM) (Gibco) to the exponential-growth phase (optical density at 600 nm [OD₆₀₀] = 0.7). RNA was extracted from three biological samples using a RiboPure bacterial RNA isolation kit (Ambion) following the manufacturer’s guidelines. The primers used in the real-time assays were designed using Primer Express v1.5 (Applied Biosystems) (63) and were validated for amplification efficiency and template specificity. Quantitative real-time PCR (qRT-PCR) was performed as previously described (21) in a one-step reaction using an ABI 7500 sequence detection system (Applied Biosystems). Data were collected using ABI Sequence detection 1.2 software (Applied Biosystems).

All data were normalized to an rpoA (RNA polymerase subunit A) endogenous control and analyzed using the comparative cycle threshold (C_T) method. Virulence gene expression was presented as fold changes over the WT expression level. Error bars indicate the standard deviations of the fold change values. The Student unpaired t test was used to determine statistical significance.

Western blots of secreted proteins.

For Western blot analyses of secreted proteins, all cultures were grown in DMEM to an OD₆₀₀ of 0.4 in the presence or absence of 50 µM epinephrine at 37°C, and proteins were isolated as previously described (31). Bovine serum albumin (BSA) (10 μg) was added to secreted proteins prior to concentration and loading such that the efficiencies of processing were known to be equivalent from sample to sample. Membranes were probed using an anti-EspB antiserum.

WT mouse infection experiments.

For mouse survival experiments, 10 3.5-week-old female C3H/HeJ or 129x1/SvJ mice per group were infected by oral gavage with multiple infectious doses of wild-type and ΔqseE and ΔqseC C. rodentium strains by oral gavage with 100 µl of PBS. Mouse survival in each group (10 animals per group) was accessed over the course of 14 to 26 days. The Kaplan-Meier test was used to determine statistical significance.

For colon weight measurement, five 3.5-week-old female C3H/HeJ or 129x1/SvJ mice per group were infected with 1 × 10⁹ cells of wild-type and ΔqseE and ΔqseC C. rodentium. The infected mice were sacrificed on day 6 postinfection, and their colons were taken, washed, and weighed.

Dbh^−/− knockout mouse assays.

Dopamine β-hydroxylase knockout (Dbh^−/−) mice, maintained with a mixed C57BL/6J and 129 SvEv background, were generated at Emory University as previously described (82) and were shipped to the University of Texas (UT) Southwestern Medical School. Next, these 129x1/Svj mice were housed in a specific-pathogen-free facility at the UT Southwestern Medical Center. All experiments were performed under IACUC-approved protocols. At 6 to 11 weeks of age, the mice were orally infected by gavage (either mock infected with PBS or orally infected with 1.3 × 10⁹ CFU of the C. rodentium WT strain [ICC168] or of ΔqseC, ΔqseE, or ΔqseCE isogenic mutants). Mice were monitored daily for survival. The experiments were performed at least twice with a total of 6 mice per group. Colonization changes and virulence gene expression levels were measured directly from RNA extracted from fecal pellets collected in triplicate daily up to day 7 postinfection. The mice were also monitored for weight changes and colon macroscopic differences after euthanization. CFU change curves reflect the averages and standard deviations (SD) of the experiment results. Littermate Dbh^+/− heterozygous mice were considered controls because they had normal NE and Epi levels (83), as previously assayed with other enteric bacteria (8). The 2-way analysis-of-variance (ANOVA) multiple-comparison test was used to determine the statistical significance of the results of the comparisons of data determined each day and among the different mutants to WT levels.

qRT-PCR for gene expression on murine stools.

The fecal pellets were collected from day 0 to day 7 after C. rodentium ICC168 infection of mice. RNA was extracted using a RiboPure Bacteria isolation kit according to the protocols of the manufacturer (Ambion). To assess host gene expression, tissue from the distal colon of infected mice was harvested on day 5 postinfection and homogenized in 1 ml TRIzol reagent (Life Technologies) per 100 mg feces or tissue. RNA was isolated using standard molecular biological procedures. The primers used for quantitative reverse transcription-PCR (qRT-PCR) of the LEE genes and the composition of the microbiota phyla (64) were validated for amplification efficiency and template specificity. qRT-PCR was performed as previously described (21) in a one-step reaction using an ABI 7500 sequence detection system (Applied Biosystems). Data were collected using ABI Sequence detection 1.2 software (Applied Biosystems).

All data were normalized to an endogenous control (rpoA for virulence gene expression in C. rodentium, Eubacteria 16S rRNA for total bacteria present in feces, or GAPDH [glyceraldehyde-3-phosphate dehydrogenase] for murine host gene expression in colonic tissue) and analyzed using the comparative cycle threshold (C_T) method. Virulence gene expression was presented as fold changes in comparison to the expression level of WT C. rodentium cultured alone in vitro or C. rodentium (DBS770) infected alone in vivo. The relative abundances of Bacteroidetes, Firmicutes, and γ-proteobacteria (family Enterobacteriaceae) were measured by quantitative PCR (qPCR) with taxon-specific or universal 16S rRNA gene primers (64). The primers used were as follows: for Eubacteria (universal bacteria), Eub338F (5-ACTCCTACGGGAGGCAGCAGT-3) and Eub338R (5-ATTACCGCGGCTGCTGGC-3); for Firmicutes, 928F-Firm (5-TGAAACTYAAAGGAATTGACG-3) and 1040FirmR (5-ACCATGCACCACCTGTC-3); for Bacteroidetes, 798cfbF (5-CRAACAGGATTAGATACCCT-3) and cfb967R (5-GGTAAGGTTCCTCGCGTAT-3); and for γ-proteobacteria, 1080gF (5-TCGTCAGCTCGTGTYGTGA-3) and g1202R (5-CGTAAGGGCCATGATG-3) (64). Expression of each taxon was normalized to Eub388 expression and then compared to the expression level present in mock-infected (PBS) fecal pellets on day 0 (D0). Percentages of taxa were determined by dividing the value corresponding to expression of the taxon-specific 16S rRNA by the value corresponding to combined expression of Firmicutes, Bacteroidetes, and γ-proteobacteria. Student’s unpaired t test was used to determine statistical significance.

Histopathology.

Portions of the distal colon and cecum were harvested 5 days postinfection with C. rodentium. The tissues were washed in PBS and then fixed in Bouin’s fixative for 48 h. The tissues were embedded in paraffin, cut into 5-µm sections, and stained with hematoxylin and eosin (H&E) in the UT Southwestern Pathology Core. Histological changes were analyzed in a double-blind fashion at Kansas State University. The severity of intestinal pathology was analyzed based on the following scoring system: for edema, 0 (no edema) to 5 (highest edema in the submucosa); for crypt integrity, 1, normal, 2, irregular crypts, 3, mild crypt loss, 4, severe crypt loss, and 5, complete crypt loss; for neutrophils, 0 for no infiltration to 6 for the highest neutrophilic infiltration in the wall; for apoptosis, 0 to 5 apoptotic cells per ×600 field (n = five fields); for bacterium attachment, 0 (no bacteria associated with the epithelial surface) to 5 (maximum number of bacteria associated with the epithelial surface); for goblet cells, average number of goblet cell in each crypt (n > 10 crypts); for vasculitis, 0 (no evidence of vasculitis) to 5 (the most severe vasculitis). The scores for each parameter represent averages of the cecum and distal colon results, taken from two independent experiments performed with 3 mice/experiment.

EHEC infant rabbit experiments.

To prepare the inoculum, bacteria were grown overnight in LB broth at 37°C with appropriate antibiotics, harvested by centrifugation, and resuspended in sterile PBS (pH 7.2) and adjusted to a cell density of ~10⁹ CFU ml⁻¹. Infant rabbit experiments were carried out as described previously (49). Briefly, 3-day-old New Zealand White rabbits were intragastrically inoculated with ~5 × 10⁸ CFU of WT EHEC or mutants using a size 5 French catheter. Rabbits were monitored twice daily for signs of illness or diarrhea. Diarrhea was described as (i) none—normal pellets were dark green, hard, and formed; (ii) mild—diarrhea consisting of a mix of soft yellow-green unformed and formed pellets resulting in light staining of the hind legs; or (iii) severe—diarrhea consisting of unformed or liquid feces, resulting in significant staining of the hind legs. Rabbits were euthanized at 2 and 5 days postinfection. At necropsy, the intestinal tract from the duodenum to the anus was removed and samples were obtained for microbiologic analyses. To limit any litter-specific effects, at least two different litters were used to test each bacterial strain.

SUPPLEMENTAL MATERIAL

FIG S1

LEE gene expression in C. rodentium. (A) qRT-PCR of ler, nleA, escV, and tir in the WT, ΔqseC, and ΔqseE strains (in DMEM; OD₆₀₀ of 0.7 at 37°C). (B) Western blot of EspB, from secreted proteins of WT ΔqseC and ΔqseE C. rodentium. BSA was used as a loading control. (C) qRT-PCR of ler and escV in the WT, ΔqseC, and ΔqseE strains and the complemented mutants (comp) (in DMEM; OD₆₀₀ of 0.7 at 37°C). ***, P < 0.001, **, P < 0.01. Download

Figure S1, PDF file, 0.1 MB^{(93.6KB, pdf)}

FIG S2

LEE gene expression in C. rodentium is activated by epinephrine in a QseC- and QseE-dependent manner. (A) Western blot of EspB, from secreted proteins of WT C. rodentium, in the absence and presence of 50 µM epinephrine. BSA was used as a loading control. (B) qRT-PCR of nleA in the WT and ΔqseC strains in the absence and presence of 50 µM epinephrine and in the complemented ΔqseC (Cpl) strain in the absence of epinephrine (in DMEM; OD₆₀₀ of 0.7 at 37°C). (C) qRT-PCR of escV in the WT and ΔqseC strains in the absence and presence of 50 μM epinephrine (in DMEM; OD₆₀₀ of 0.7 at 37°C). (D) qRT-PCR of nleA in the WT and ΔqseE strains in the absence and presence of 50 μM epinephrine (in DMEM; OD₆₀₀ of 0.7 at 37°C). ***, P < 0.001. Download

Figure S2, PDF file, 0.1 MB^{(100.8KB, pdf)}

FIG S3

C. rodentium infection of 129x1/SvJ mice. (A) Survival curves. (B) Colon weights at day 7 postinfection. (C) Gross pathology of colons at day 7 postinfection. Download

Figure S3, PDF file, 0.1 MB^{(103.2KB, pdf)}

ACKNOWLEDGMENTS

We thank members of the Sperandio laboratory for collegial discussions of this work. We thank David Rasko from the University of Maryland Medical School for the alignments of the LEE regions in Fig. 3.

This work was supported by National Institutes of Health (NIH) grants AI101472, AI05135, and AI053067. M.M.C. was supported through NIH Training Grant 5 T32 AI7520-14.

The contents are solely our responsibility and do not represent the official views of the NIH NIAID.

Footnotes

Citation Moreira CG, Russell R, Mishra AA, Narayanan S, Ritchie JM, Waldor MK, Curtis MM, Winter SE, Weinshenker D, Sperandio V. 2016. Bacterial adrenergic sensors regulate virulence of enteric pathogens in the gut. mBio 7(3):e00826-16. doi:10.1128/mBio.00826-16.

REFERENCES

1.Grenham S, Clarke G, Cryan JF, Dinan TG. 2011. Brain-gut-microbe communication in health and disease. Front Physiol 2:94. doi: 10.3389/fphys.2011.00094. [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Furness JB. 2000. Types of neurons in the enteric nervous system. J Auton Nerv Syst 81:87–96. doi: 10.1016/S0165-1838(00)00127-2. [DOI] [PubMed] [Google Scholar]
3.Purves D, Fitzpatrick D, Williams SM, McNamara JO, Augustine GJ, Katz LC, LaMantia A. 2001. Neuroscience, 2nd ed. Sinauer Associates, Inc., Sunderland, MA. doi: 10.4249/scholarpedia.7204. [DOI] [Google Scholar]
4.Hörger S, Schultheiss G, Diener M. 1998. Segment-specific effects of epinephrine on ion transport in the colon of the rat. Am J Physiol 275:G1367–G1376. [DOI] [PubMed] [Google Scholar]
5.Asano Y, Hiramoto T, Nishino R, Aiba Y, Kimura T, Yoshihara K, Koga Y, Sudo N. 2012. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 303:G1288–G1295. doi: 10.1152/ajpgi.00341.2012. [DOI] [PubMed] [Google Scholar]
6.Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ. 2012. Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection. Infect Immun 80:2826–2834. doi: 10.1128/IAI.00283-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
7.Rasko DA, Moreira CG, Li DR, Reading NC, Ritchie JM, Waldor MK, Williams N, Taussig R, Wei S, Roth M, Hughes DT, Huntley JF, Fina MW, Falck JR, Sperandio V. 2008. Targeting QseC signaling and virulence for antibiotic development. Science 321:1078–1080. doi: 10.1126/science.1160354. [DOI] [PMC free article] [PubMed] [Google Scholar]
8.Moreira CG, Weinshenker D, Sperandio V. 2010. QseC mediates Salmonella enterica serovar Typhimurium virulence in vitro and in vivo. Infect Immun 78:914–926. doi: 10.1128/IAI.01038-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
9.Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. 2009. QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol Microbiol 73:1020–1031. doi: 10.1111/j.1365-2958.2009.06826.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, Monack DM. 2007. In vivo negative selection screen identifies genes required for Francisella virulence. Proc Natl Acad Sci U S A 104:6037–6042. doi: 10.1073/pnas.0609675104. [DOI] [PMC free article] [PubMed] [Google Scholar]
11.Moreira CG, Sperandio V. 2012. Interplay between the QseC and QseE bacterial adrenergic sensor kinases in Salmonella enterica serovar Typhimurium pathogenesis. Infect Immun 80:4344–4353. doi: 10.1128/IAI.00803-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
12.Unal CM, Singh B, Fleury C, Singh K, Chávez de Paz L, Svensäter G, Riesbeck K. 2012. QseC controls biofilm formation of non-typeable Haemophilus influenzae in addition to an AI-2-dependent mechanism. Int J Med Microbiol 302:261–269. doi: 10.1016/j.ijmm.2012.07.013. [DOI] [PubMed] [Google Scholar]
13.Khajanchi BK, Kozlova EV, Sha J, Popov VL, Chopra AK. 2012. The two-component QseBC signalling system regulates in vitro and in vivo virulence of Aeromonas hydrophila. Microbiology 158:259–271. doi: 10.1099/mic.0.051805-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
14.Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ. 2012. Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection. Infect Immun 80:2826–2834. doi: 10.1128/IAI.00283-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ. 2011. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol 80:1516–1529. doi: 10.1111/j.1365-2958.2011.07660.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
16.Novak EA, Shao H, Daep CA, Demuth DR. 2010. Autoinducer-2 and QseC control biofilm formation and in vivo virulence of Aggregatibacter actinomycetemcomitans. Infect Immun 78:2919–2926. doi: 10.1128/IAI.01376-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
17.Mokrievich AN, Kondakova AN, Valade E, Platonov ME, Vakhrameeva GM, Shaikhutdinova RZ, Mironova RI, Blaha D, Bakhteeva IV, Titareva GM, Kravchenko TB, Kombarova TI, Vidal D, Pavlov VM, Lindner B, Dyatlov IA, Knirel YA. 2010. Biological properties and structure of the lipopolysaccharide of a vaccine strain of Francisella tularensis generated by inactivation of a quorum sensing system gene qseC. Biochemistry (Mosc) 75:443–451. [DOI] [PubMed] [Google Scholar]
18.Wang X, Wang Q, Yang M, Xiao J, Liu Q, Wu H, Zhang Y. 2011. QseBC controls flagellar motility, fimbrial hemagglutination and intracellular virulence in fish pathogen Edwardsiella tarda. Fish Shellfish Immunol 30:944–953. doi: 10.1016/j.fsi.2011.01.019. [DOI] [PubMed] [Google Scholar]
19.Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB. 2003. Bacteria-host communication: the language of hormones. Proc Natl Acad Sci U S A 100:8951–8956. doi: 10.1073/pnas.1537100100. [DOI] [PMC free article] [PubMed] [Google Scholar]
20.Clarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V. 2006. The QseC sensor kinase: a bacterial adrenergic receptor. Proc Natl Acad Sci U S A 103:10420–10425. doi: 10.1073/pnas.0604343103. [DOI] [PMC free article] [PubMed] [Google Scholar]
21.Hughes DT, Clarke MB, Yamamoto K, Rasko DA, Sperandio V. 2009. The QseC adrenergic signaling cascade in enterohemorrhagic E. coli (EHEC). PLoS Pathog 5:e00826-16. doi: 10.1371/journal.ppat.1000553. [DOI] [PMC free article] [PubMed] [Google Scholar]
22.Kendall MM, Rasko DA, Sperandio V. 2007. Global effects of the cell-to-cell signaling molecules Autoinducer-2, Autoinducer-3, and epinephrine in a luxS mutant of enterohemorrhagic Escherichia coli. Infect Immun 75:4875–4884. doi: 10.1128/IAI.00550-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
23.Reading NC, Rasko DA, Torres AG, Sperandio V. 2009. The two-component system QseEF and the membrane protein QseG link adrenergic and stress sensing to bacterial pathogenesis. Proc Natl Acad Sci U S A 106:5889–5894. doi: 10.1073/pnas.0811409106. [DOI] [PMC free article] [PubMed] [Google Scholar]
24.Njoroge J, Sperandio V. 2012. Enterohemorrhagic Escherichia coli virulence regulation by two bacterial adrenergic kinases, QseC and QseE. Infect Immun 80:688–703. doi: 10.1128/IAI.05921-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
25.Walters M, Sperandio V. 2006. Autoinducer 3 and epinephrine signaling in the kinetics of locus of enterocyte effacement gene expression in enterohemorrhagic Escherichia coli. Infect Immun 74:5445–5455. doi: 10.1128/IAI.00099-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
26.Kendall MM, Rasko DA, Sperandio V. 2007. Global effects of the cell-to-cell signaling molecules autoinducer-2, autoinducer-3, and epinephrine in a luxS mutant of enterohemorrhagic Escherichia coli. Infect Immun 75:4875–4884. doi: 10.1128/IAI.00550-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
27.Kaper JB, O’Brien AD (ed). 1998. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains, 1st ed. ASM Press, Washington, DC. [Google Scholar]
28.Elliott SJ, Hutcheson SW, Dubois MS, Mellies JL, Wainwright LA, Batchelor M, Frankel G, Knutton S, Kaper JB. 1999. Identification of CesT, a chaperone for the type III secretion of Tir in enteropathogenic Escherichia coli. Mol Microbiol 33:1176–1189. doi: 10.1046/j.1365-2958.1999.01559.x. [DOI] [PubMed] [Google Scholar]
29.Mellies JL, Elliott SJ, Sperandio V, Donnenberg MS, Kaper JB. 1999. The per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol Microbiol 33:296–306. doi: 10.1046/j.1365-2958.1999.01473.x. [DOI] [PubMed] [Google Scholar]
30.Elliott SJ, Wainwright LA, McDaniel TK, Jarvis KG, Deng Y, Lai L, McNamara BP, Donnenberg MS, Kaper JB. 1998. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol 28:1–4. doi: 10.1046/j.1365-2958.1998.00783.x. [DOI] [PubMed] [Google Scholar]
31.Jarvis KG, Girón JA, Jerse AE, McDaniel TK, Donnenberg MS, Kaper JB. 1995. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci U S A 92:7996–8000. doi: 10.1073/pnas.92.17.7996. [DOI] [PMC free article] [PubMed] [Google Scholar]
32.Jerse AE, Yu J, Tall BD, Kaper JB. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 87:7839–7843. doi: 10.1073/pnas.87.20.7839. [DOI] [PMC free article] [PubMed] [Google Scholar]
33.Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511–520. doi: 10.1016/S0092-8674(00)80437-7. [DOI] [PubMed] [Google Scholar]
34.McNamara BP, Donnenberg MS. 1998. A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway. FEMS Microbiol Lett 166:71–78. doi: 10.1111/j.1574-6968.1998.tb13185.x. [DOI] [PubMed] [Google Scholar]
35.Kenny B, Jepson M. 2000. Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell Microbiol 2:579–590. doi: 10.1046/j.1462-5822.2000.00082.x. [DOI] [PubMed] [Google Scholar]
36.Elliott SJ, Krejany EO, Mellies JL, Robins-Browne RM, Sasakawa C, Kaper JB. 2001. EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect Immun 69:4027–4033. doi: 10.1128/IAI.69.6.4027-4033.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
37.Tu X, Nisan I, Yona C, Hanski E, Rosenshine I. 2003. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol 47:595–606. doi: 10.1046/j.1365-2958.2003.03329.x. [DOI] [PubMed] [Google Scholar]
38.Kanack KJ, Crawford JA, Tatsuno I, Karmali MA, Kaper JB. 2005. SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun 73:4327–4337. doi: 10.1128/IAI.73.7.4327-4337.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
39.Dean-Nystrom EA, Bosworth BT, Cray WC Jr, Moon HW. 1997. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun 65:1842–1848. [DOI] [PMC free article] [PubMed] [Google Scholar]
40.Dean-Nystrom EA, Bosworth BT, Moon HW, O’Brien AD. 1998. Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves. Infect Immun 66:4560–4563. [DOI] [PMC free article] [PubMed] [Google Scholar]
41.Dean-Nystrom EA, Gansheroff LJ, Mills M, Moon HW, O’Brien AD. 2002. Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection. Infect Immun 70:2414–2418. doi: 10.1128/IAI.70.5.2414-2418.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
42.Dean-Nystrom EA, Pohlenz JF, Moon HW, O’Brien AD. 2000. Escherichia coli O157:H7 causes more-severe systemic disease in suckling piglets than in colostrum-deprived neonatal piglets. Infect Immun 68:2356–2358. doi: 10.1128/IAI.68.4.2356-2358.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
43.McKee ML, Melton-Celsa AR, Moxley RA, Francis DH, O’Brien AD. 1995. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun 63:3739–3744. [DOI] [PMC free article] [PubMed] [Google Scholar]
44.Wadolkowski EA, Burris JA, O’Brien AD. 1990. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 58:2438–2445. [DOI] [PMC free article] [PubMed] [Google Scholar]
45.Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O’Brien AD. 1990. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 58:3959–3965. [DOI] [PMC free article] [PubMed] [Google Scholar]
46.Woods JB, Schmitt CK, Darnell SC, Meysick KC, O’Brien AD. 2002. Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli. J Infect Dis 185:550–554. doi: 10.1086/338633. [DOI] [PubMed] [Google Scholar]
47.Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, Taylor FB. 2003. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92–96. doi: 10.1007/s00467-002-1035-7. [DOI] [PubMed] [Google Scholar]
48.Siegler RL, Pysher TJ, Tesh VL, Taylor FB. 2002. Renal prostacyclin biosynthesis in a baboon model of Shiga toxin mediated hemolytic uremic syndrome. Nephron 92:363–368. [DOI] [PubMed] [Google Scholar]
49.Ritchie JM, Thorpe CM, Rogers AB, Waldor MK. 2003. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun 71:7129–7139. doi: 10.1128/IAI.71.12.7129-7139.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
50.Ritchie JM, Waldor MK. 2005. The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits. Infect Immun 73:1466–1474. doi: 10.1128/IAI.73.3.1466-1474.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
51.Mundy R, Pickard D, Wilson RK, Simmons CP, Dougan G, Frankel G. 2003. Identification of a novel type IV pilus gene cluster required for gastrointestinal colonization of Citrobacter rodentium. Mol Microbiol 48:795–809. doi: 10.1046/j.1365-2958.2003.03470.x. [DOI] [PubMed] [Google Scholar]
52.Deng W, Puente JL, Gruenheid S, Li Y, Vallance BA, Vázquez A, Barba J, Ibarra JA, O’Donnell P, Metalnikov P, Ashman K, Lee S, Goode D, Pawson T, Finlay BB. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A 101:3597–3602. doi: 10.1073/pnas.0400326101. [DOI] [PMC free article] [PubMed] [Google Scholar]
53.Finlay BB. 1999. Bacterial disease in diverse hosts. Cell 96:315–318. doi: 10.1016/S0092-8674(00)80544-9. [DOI] [PubMed] [Google Scholar]
54.Gruenheid S, Sekirov I, Thomas NA, Deng W, O’Donnell P, Goode D, Li Y, Frey EA, Brown NF, Metalnikov P, Pawson T, Ashman K, Finlay BB. 2004. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 51:1233–1249. doi: 10.1046/j.1365-2958.2003.03911.x. [DOI] [PubMed] [Google Scholar]
55.Dougan G, Ghaem-Maghami M, Pickard D, Frankel G, Douce G, Clare S, Dunstan S, Simmons C. 2000. The immune responses to bacterial antigens encountered in vivo at mucosal surfaces. Philos Trans R Soc Lond B Biol Sci 355:705-712. doi: 10.1098/rstb.2000.0610. [DOI] [PMC free article] [PubMed] [Google Scholar]
56.Hemrajani C, Marches O, Wiles S, Girard F, Dennis A, Dziva F, Best A, Phillips AD, Berger CN, Mousnier A, Crepin VF, Kruidenier L, Woodward MJ, Stevens MP, La Ragione RM, Macdonald TT, Frankel G. 2008. Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun 76:4804–4813. doi: 10.1128/IAI.00742-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
57.Reading NC, Torres AG, Kendall MM, Hughes DT, Yamamoto K, Sperandio V. 2007. A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J Bacteriol 189:2468–2476. doi: 10.1128/JB.01848-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
58.Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat Rev Microbiol 2:123–140. doi: 10.1038/nrmicro818. [DOI] [PubMed] [Google Scholar]
59.Njoroge JW, Nguyen Y, Curtis MM, Moreira CG, Sperandio V. 2012. Virulence meets metabolism: CRA and KdpE gene regulation in enterohemorrhagic Escherichia coli. mBio 3:e00826-16. doi: 10.1128/mBio.00280-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
60.García-Angulo VA, Martínez-Santos VI, Villaseñor T, Santana FJ, Huerta-Saquero A, Martínez LC, Jiménez R, Lara-Ochoa C, Téllez-Sosa J, Bustamante VH, Puente JL. 2012. A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli. J Bacteriol 194:5589–5603. doi: 10.1128/JB.00190-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
61.Gruber CC, Sperandio V. 2014. Posttranscriptional control of microbe-induced rearrangement of host cell actin. mBio 5:e00826-16. doi: 10.1128/mBio.01025-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
62.Gruber CC, Sperandio V. 2015. Global analysis of posttranscriptional regulation by GlmY and GlmZ in enterohemorrhagic Escherichia coli O157:H7. Infect Immun 83:1286–1295. doi: 10.1128/IAI.02918-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
63.Curtis MM, Russell R, Moreira CG, Adebesin AM, Wang C, Williams NS, Taussig R, Stewart D, Zimmern P, Lu B, Prasad RN, Zhu C, Rasko DA, Huntley JF, Falck JR, Sperandio V. 2014. QseC inhibitors as an antivirulence approach for gram-negative pathogens. mBio 5:e00826-16. doi: 10.1128/mBio.02165-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
64.Curtis MM, Hu Z, Klimko C, Narayanan S, Deberardinis R, Sperandio V. 2014. The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 16:759–769. doi: 10.1016/j.chom.2014.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
65.Luperchio SA, Schauer DB. 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3:333–340. doi: 10.1016/S1286-4579(01)01387-9. [DOI] [PubMed] [Google Scholar]
66.Alaniz RC, Thomas SA, Perez-Melgosa M, Mueller K, Farr AG, Palmiter RD, Wilson CB. 1999. Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proc Natl Acad Sci U S A 96:2274–2278. doi: 10.1073/pnas.96.5.2274. [DOI] [PMC free article] [PubMed] [Google Scholar]
67.Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, Moreira CG, Sperandio V. 2012. Fucose sensing regulates bacterial intestinal colonization. Nature 492:113–117. doi: 10.1038/nature11623. [DOI] [PMC free article] [PubMed] [Google Scholar]
68.Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC, Núñez G. 2012. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336:1325–1329. doi: 10.1126/science.1222195. [DOI] [PMC free article] [PubMed] [Google Scholar]
69.Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, Finlay BB. 2011. Altering host resistance to infections through microbial transplantation. PLoS One 6:e00826-16. doi: 10.1371/journal.pone.0026988. [DOI] [PMC free article] [PubMed] [Google Scholar]
70.Spencer H, Karavolos MH, Bulmer DM, Aldridge P, Chhabra SR, Winzer K, Williams P, Khan CM. 2010. Genome-wide transposon mutagenesis identifies a role for host neuroendocrine stress hormones in regulating the expression of virulence genes in salmonella. J Bacteriol 192:714–724. doi: 10.1128/JB.01329-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
71.Hughes DT, Sperandio V. 2008. Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol 6:111–120. doi: 10.1038/nrmicro1836. [DOI] [PMC free article] [PubMed] [Google Scholar]
72.Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY. 2015. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:264–276. doi: 10.1016/j.cell.2015.02.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
73.Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. 2007. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2:204. doi: 10.1016/j.chom.2007.08.002. [DOI] [PubMed] [Google Scholar]
74.Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J, Dougan G, von Mering C, Hardt WD. 2007. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5:2177–2189. doi: 10.1371/journal.pbio.0050244. [DOI] [PMC free article] [PubMed] [Google Scholar]
75.Yamamoto K, Hirao K, Oshima T, Aiba H, Utsumi R, Ishihama A. 2005. Functional characterization in vitro of all two-component signal transduction systems from Escherichia coli. J Biol Chem 280:1448–1456. doi: 10.1074/jbc.M410104200. [DOI] [PubMed] [Google Scholar]
76.Kendall MM, Gruber CC, Rasko DA, Hughes DT, Sperandio V. 2011. Hfq virulence regulation in enterohemorrhagic Escherichia coli O157:H7 strain 86-24. J Bacteriol 193:6843–6851. doi: 10.1128/JB.06141-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
77.Shakhnovich EA, Davis BM, Waldor MK. 2009. Hfq negatively regulates type III secretion in EHEC and several other pathogens. Mol Microbiol 74:347–363. doi: 10.1111/j.1365-2958.2009.06856.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
78.Hansen AM, Kaper JB. 2009. Hfq affects the expression of the LEE pathogenicity island in enterohaemorrhagic Escherichia coli. Mol Microbiol 73:446–465. doi: 10.1111/j.1365-2958.2009.06781.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
79.Schauer DB, Falkow S. 1993. Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect Immun 61:2486–2492. [DOI] [PMC free article] [PubMed] [Google Scholar]
80.Sampson TR, Mazmanian SK. 2015. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17:565–576. doi: 10.1016/j.chom.2015.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
81.Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645. doi: 10.1073/pnas.120163297. [DOI] [PMC free article] [PubMed] [Google Scholar]
82.Ahmer BM, Thomas MG, Larsen RA, Postle K. 1995. Characterization of the exbBD operon of Escherichia coli and the role of ExbB and ExbD in TonB function and stability. J Bacteriol 177:4742–4747. [DOI] [PMC free article] [PubMed] [Google Scholar]
83.Thomas SA, Palmiter RD. 1998. Examining adrenergic roles in development, physiology, and behavior through targeted disruption of the mouse dopamine beta-hydroxylase gene. Adv Pharmacol 42:57–60. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

FIG S1

Figure S1, PDF file, 0.1 MB^{(93.6KB, pdf)}

FIG S2

Figure S2, PDF file, 0.1 MB^{(100.8KB, pdf)}

FIG S3

C. rodentium infection of 129x1/SvJ mice. (A) Survival curves. (B) Colon weights at day 7 postinfection. (C) Gross pathology of colons at day 7 postinfection. Download

Figure S3, PDF file, 0.1 MB^{(103.2KB, pdf)}

[B1] 1.Grenham S, Clarke G, Cryan JF, Dinan TG. 2011. Brain-gut-microbe communication in health and disease. Front Physiol 2:94. doi: 10.3389/fphys.2011.00094. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B2] 2.Furness JB. 2000. Types of neurons in the enteric nervous system. J Auton Nerv Syst 81:87–96. doi: 10.1016/S0165-1838(00)00127-2. [DOI] [PubMed] [Google Scholar]

[B3] 3.Purves D, Fitzpatrick D, Williams SM, McNamara JO, Augustine GJ, Katz LC, LaMantia A. 2001. Neuroscience, 2nd ed. Sinauer Associates, Inc., Sunderland, MA. doi: 10.4249/scholarpedia.7204. [DOI] [Google Scholar]

[B4] 4.Hörger S, Schultheiss G, Diener M. 1998. Segment-specific effects of epinephrine on ion transport in the colon of the rat. Am J Physiol 275:G1367–G1376. [DOI] [PubMed] [Google Scholar]

[B5] 5.Asano Y, Hiramoto T, Nishino R, Aiba Y, Kimura T, Yoshihara K, Koga Y, Sudo N. 2012. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 303:G1288–G1295. doi: 10.1152/ajpgi.00341.2012. [DOI] [PubMed] [Google Scholar]

[B6] 6.Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ. 2012. Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection. Infect Immun 80:2826–2834. doi: 10.1128/IAI.00283-12. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B7] 7.Rasko DA, Moreira CG, Li DR, Reading NC, Ritchie JM, Waldor MK, Williams N, Taussig R, Wei S, Roth M, Hughes DT, Huntley JF, Fina MW, Falck JR, Sperandio V. 2008. Targeting QseC signaling and virulence for antibiotic development. Science 321:1078–1080. doi: 10.1126/science.1160354. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B8] 8.Moreira CG, Weinshenker D, Sperandio V. 2010. QseC mediates Salmonella enterica serovar Typhimurium virulence in vitro and in vivo. Infect Immun 78:914–926. doi: 10.1128/IAI.01038-09. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B9] 9.Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. 2009. QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol Microbiol 73:1020–1031. doi: 10.1111/j.1365-2958.2009.06826.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B10] 10.Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, Monack DM. 2007. In vivo negative selection screen identifies genes required for Francisella virulence. Proc Natl Acad Sci U S A 104:6037–6042. doi: 10.1073/pnas.0609675104. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B11] 11.Moreira CG, Sperandio V. 2012. Interplay between the QseC and QseE bacterial adrenergic sensor kinases in Salmonella enterica serovar Typhimurium pathogenesis. Infect Immun 80:4344–4353. doi: 10.1128/IAI.00803-12. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B12] 12.Unal CM, Singh B, Fleury C, Singh K, Chávez de Paz L, Svensäter G, Riesbeck K. 2012. QseC controls biofilm formation of non-typeable Haemophilus influenzae in addition to an AI-2-dependent mechanism. Int J Med Microbiol 302:261–269. doi: 10.1016/j.ijmm.2012.07.013. [DOI] [PubMed] [Google Scholar]

[B13] 13.Khajanchi BK, Kozlova EV, Sha J, Popov VL, Chopra AK. 2012. The two-component QseBC signalling system regulates in vitro and in vivo virulence of Aeromonas hydrophila. Microbiology 158:259–271. doi: 10.1099/mic.0.051805-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B14] 14.Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ. 2012. Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection. Infect Immun 80:2826–2834. doi: 10.1128/IAI.00283-12. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B15] 15.Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ. 2011. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol 80:1516–1529. doi: 10.1111/j.1365-2958.2011.07660.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B16] 16.Novak EA, Shao H, Daep CA, Demuth DR. 2010. Autoinducer-2 and QseC control biofilm formation and in vivo virulence of Aggregatibacter actinomycetemcomitans. Infect Immun 78:2919–2926. doi: 10.1128/IAI.01376-09. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B17] 17.Mokrievich AN, Kondakova AN, Valade E, Platonov ME, Vakhrameeva GM, Shaikhutdinova RZ, Mironova RI, Blaha D, Bakhteeva IV, Titareva GM, Kravchenko TB, Kombarova TI, Vidal D, Pavlov VM, Lindner B, Dyatlov IA, Knirel YA. 2010. Biological properties and structure of the lipopolysaccharide of a vaccine strain of Francisella tularensis generated by inactivation of a quorum sensing system gene qseC. Biochemistry (Mosc) 75:443–451. [DOI] [PubMed] [Google Scholar]

[B18] 18.Wang X, Wang Q, Yang M, Xiao J, Liu Q, Wu H, Zhang Y. 2011. QseBC controls flagellar motility, fimbrial hemagglutination and intracellular virulence in fish pathogen Edwardsiella tarda. Fish Shellfish Immunol 30:944–953. doi: 10.1016/j.fsi.2011.01.019. [DOI] [PubMed] [Google Scholar]

[B19] 19.Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB. 2003. Bacteria-host communication: the language of hormones. Proc Natl Acad Sci U S A 100:8951–8956. doi: 10.1073/pnas.1537100100. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B20] 20.Clarke MB, Hughes DT, Zhu C, Boedeker EC, Sperandio V. 2006. The QseC sensor kinase: a bacterial adrenergic receptor. Proc Natl Acad Sci U S A 103:10420–10425. doi: 10.1073/pnas.0604343103. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B21] 21.Hughes DT, Clarke MB, Yamamoto K, Rasko DA, Sperandio V. 2009. The QseC adrenergic signaling cascade in enterohemorrhagic E. coli (EHEC). PLoS Pathog 5:e00826-16. doi: 10.1371/journal.ppat.1000553. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B22] 22.Kendall MM, Rasko DA, Sperandio V. 2007. Global effects of the cell-to-cell signaling molecules Autoinducer-2, Autoinducer-3, and epinephrine in a luxS mutant of enterohemorrhagic Escherichia coli. Infect Immun 75:4875–4884. doi: 10.1128/IAI.00550-07. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B23] 23.Reading NC, Rasko DA, Torres AG, Sperandio V. 2009. The two-component system QseEF and the membrane protein QseG link adrenergic and stress sensing to bacterial pathogenesis. Proc Natl Acad Sci U S A 106:5889–5894. doi: 10.1073/pnas.0811409106. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B24] 24.Njoroge J, Sperandio V. 2012. Enterohemorrhagic Escherichia coli virulence regulation by two bacterial adrenergic kinases, QseC and QseE. Infect Immun 80:688–703. doi: 10.1128/IAI.05921-11. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B25] 25.Walters M, Sperandio V. 2006. Autoinducer 3 and epinephrine signaling in the kinetics of locus of enterocyte effacement gene expression in enterohemorrhagic Escherichia coli. Infect Immun 74:5445–5455. doi: 10.1128/IAI.00099-06. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B26] 26.Kendall MM, Rasko DA, Sperandio V. 2007. Global effects of the cell-to-cell signaling molecules autoinducer-2, autoinducer-3, and epinephrine in a luxS mutant of enterohemorrhagic Escherichia coli. Infect Immun 75:4875–4884. doi: 10.1128/IAI.00550-07. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B27] 27.Kaper JB, O’Brien AD (ed). 1998. Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains, 1st ed. ASM Press, Washington, DC. [Google Scholar]

[B28] 28.Elliott SJ, Hutcheson SW, Dubois MS, Mellies JL, Wainwright LA, Batchelor M, Frankel G, Knutton S, Kaper JB. 1999. Identification of CesT, a chaperone for the type III secretion of Tir in enteropathogenic Escherichia coli. Mol Microbiol 33:1176–1189. doi: 10.1046/j.1365-2958.1999.01559.x. [DOI] [PubMed] [Google Scholar]

[B29] 29.Mellies JL, Elliott SJ, Sperandio V, Donnenberg MS, Kaper JB. 1999. The per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol Microbiol 33:296–306. doi: 10.1046/j.1365-2958.1999.01473.x. [DOI] [PubMed] [Google Scholar]

[B30] 30.Elliott SJ, Wainwright LA, McDaniel TK, Jarvis KG, Deng Y, Lai L, McNamara BP, Donnenberg MS, Kaper JB. 1998. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol 28:1–4. doi: 10.1046/j.1365-2958.1998.00783.x. [DOI] [PubMed] [Google Scholar]

[B31] 31.Jarvis KG, Girón JA, Jerse AE, McDaniel TK, Donnenberg MS, Kaper JB. 1995. Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci U S A 92:7996–8000. doi: 10.1073/pnas.92.17.7996. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B32] 32.Jerse AE, Yu J, Tall BD, Kaper JB. 1990. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 87:7839–7843. doi: 10.1073/pnas.87.20.7839. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B33] 33.Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, Finlay BB. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91:511–520. doi: 10.1016/S0092-8674(00)80437-7. [DOI] [PubMed] [Google Scholar]

[B34] 34.McNamara BP, Donnenberg MS. 1998. A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway. FEMS Microbiol Lett 166:71–78. doi: 10.1111/j.1574-6968.1998.tb13185.x. [DOI] [PubMed] [Google Scholar]

[B35] 35.Kenny B, Jepson M. 2000. Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell Microbiol 2:579–590. doi: 10.1046/j.1462-5822.2000.00082.x. [DOI] [PubMed] [Google Scholar]

[B36] 36.Elliott SJ, Krejany EO, Mellies JL, Robins-Browne RM, Sasakawa C, Kaper JB. 2001. EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect Immun 69:4027–4033. doi: 10.1128/IAI.69.6.4027-4033.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B37] 37.Tu X, Nisan I, Yona C, Hanski E, Rosenshine I. 2003. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol 47:595–606. doi: 10.1046/j.1365-2958.2003.03329.x. [DOI] [PubMed] [Google Scholar]

[B38] 38.Kanack KJ, Crawford JA, Tatsuno I, Karmali MA, Kaper JB. 2005. SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system. Infect Immun 73:4327–4337. doi: 10.1128/IAI.73.7.4327-4337.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B39] 39.Dean-Nystrom EA, Bosworth BT, Cray WC Jr, Moon HW. 1997. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun 65:1842–1848. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B40] 40.Dean-Nystrom EA, Bosworth BT, Moon HW, O’Brien AD. 1998. Escherichia coli O157:H7 requires intimin for enteropathogenicity in calves. Infect Immun 66:4560–4563. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B41] 41.Dean-Nystrom EA, Gansheroff LJ, Mills M, Moon HW, O’Brien AD. 2002. Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection. Infect Immun 70:2414–2418. doi: 10.1128/IAI.70.5.2414-2418.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B42] 42.Dean-Nystrom EA, Pohlenz JF, Moon HW, O’Brien AD. 2000. Escherichia coli O157:H7 causes more-severe systemic disease in suckling piglets than in colostrum-deprived neonatal piglets. Infect Immun 68:2356–2358. doi: 10.1128/IAI.68.4.2356-2358.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B43] 43.McKee ML, Melton-Celsa AR, Moxley RA, Francis DH, O’Brien AD. 1995. Enterohemorrhagic Escherichia coli O157:H7 requires intimin to colonize the gnotobiotic pig intestine and to adhere to HEp-2 cells. Infect Immun 63:3739–3744. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B44] 44.Wadolkowski EA, Burris JA, O’Brien AD. 1990. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 58:2438–2445. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B45] 45.Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O’Brien AD. 1990. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 58:3959–3965. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B46] 46.Woods JB, Schmitt CK, Darnell SC, Meysick KC, O’Brien AD. 2002. Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli. J Infect Dis 185:550–554. doi: 10.1086/338633. [DOI] [PubMed] [Google Scholar]

[B47] 47.Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, Taylor FB. 2003. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18:92–96. doi: 10.1007/s00467-002-1035-7. [DOI] [PubMed] [Google Scholar]

[B48] 48.Siegler RL, Pysher TJ, Tesh VL, Taylor FB. 2002. Renal prostacyclin biosynthesis in a baboon model of Shiga toxin mediated hemolytic uremic syndrome. Nephron 92:363–368. [DOI] [PubMed] [Google Scholar]

[B49] 49.Ritchie JM, Thorpe CM, Rogers AB, Waldor MK. 2003. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun 71:7129–7139. doi: 10.1128/IAI.71.12.7129-7139.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B50] 50.Ritchie JM, Waldor MK. 2005. The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits. Infect Immun 73:1466–1474. doi: 10.1128/IAI.73.3.1466-1474.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B51] 51.Mundy R, Pickard D, Wilson RK, Simmons CP, Dougan G, Frankel G. 2003. Identification of a novel type IV pilus gene cluster required for gastrointestinal colonization of Citrobacter rodentium. Mol Microbiol 48:795–809. doi: 10.1046/j.1365-2958.2003.03470.x. [DOI] [PubMed] [Google Scholar]

[B52] 52.Deng W, Puente JL, Gruenheid S, Li Y, Vallance BA, Vázquez A, Barba J, Ibarra JA, O’Donnell P, Metalnikov P, Ashman K, Lee S, Goode D, Pawson T, Finlay BB. 2004. Dissecting virulence: systematic and functional analyses of a pathogenicity island. Proc Natl Acad Sci U S A 101:3597–3602. doi: 10.1073/pnas.0400326101. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B53] 53.Finlay BB. 1999. Bacterial disease in diverse hosts. Cell 96:315–318. doi: 10.1016/S0092-8674(00)80544-9. [DOI] [PubMed] [Google Scholar]

[B54] 54.Gruenheid S, Sekirov I, Thomas NA, Deng W, O’Donnell P, Goode D, Li Y, Frey EA, Brown NF, Metalnikov P, Pawson T, Ashman K, Finlay BB. 2004. Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 51:1233–1249. doi: 10.1046/j.1365-2958.2003.03911.x. [DOI] [PubMed] [Google Scholar]

[B55] 55.Dougan G, Ghaem-Maghami M, Pickard D, Frankel G, Douce G, Clare S, Dunstan S, Simmons C. 2000. The immune responses to bacterial antigens encountered in vivo at mucosal surfaces. Philos Trans R Soc Lond B Biol Sci 355:705-712. doi: 10.1098/rstb.2000.0610. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B56] 56.Hemrajani C, Marches O, Wiles S, Girard F, Dennis A, Dziva F, Best A, Phillips AD, Berger CN, Mousnier A, Crepin VF, Kruidenier L, Woodward MJ, Stevens MP, La Ragione RM, Macdonald TT, Frankel G. 2008. Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun 76:4804–4813. doi: 10.1128/IAI.00742-08. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B57] 57.Reading NC, Torres AG, Kendall MM, Hughes DT, Yamamoto K, Sperandio V. 2007. A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J Bacteriol 189:2468–2476. doi: 10.1128/JB.01848-06. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B58] 58.Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat Rev Microbiol 2:123–140. doi: 10.1038/nrmicro818. [DOI] [PubMed] [Google Scholar]

[B59] 59.Njoroge JW, Nguyen Y, Curtis MM, Moreira CG, Sperandio V. 2012. Virulence meets metabolism: CRA and KdpE gene regulation in enterohemorrhagic Escherichia coli. mBio 3:e00826-16. doi: 10.1128/mBio.00280-12. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B60] 60.García-Angulo VA, Martínez-Santos VI, Villaseñor T, Santana FJ, Huerta-Saquero A, Martínez LC, Jiménez R, Lara-Ochoa C, Téllez-Sosa J, Bustamante VH, Puente JL. 2012. A distinct regulatory sequence is essential for the expression of a subset of nle genes in attaching and effacing Escherichia coli. J Bacteriol 194:5589–5603. doi: 10.1128/JB.00190-12. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B61] 61.Gruber CC, Sperandio V. 2014. Posttranscriptional control of microbe-induced rearrangement of host cell actin. mBio 5:e00826-16. doi: 10.1128/mBio.01025-13. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B62] 62.Gruber CC, Sperandio V. 2015. Global analysis of posttranscriptional regulation by GlmY and GlmZ in enterohemorrhagic Escherichia coli O157:H7. Infect Immun 83:1286–1295. doi: 10.1128/IAI.02918-14. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B63] 63.Curtis MM, Russell R, Moreira CG, Adebesin AM, Wang C, Williams NS, Taussig R, Stewart D, Zimmern P, Lu B, Prasad RN, Zhu C, Rasko DA, Huntley JF, Falck JR, Sperandio V. 2014. QseC inhibitors as an antivirulence approach for gram-negative pathogens. mBio 5:e00826-16. doi: 10.1128/mBio.02165-14. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B64] 64.Curtis MM, Hu Z, Klimko C, Narayanan S, Deberardinis R, Sperandio V. 2014. The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 16:759–769. doi: 10.1016/j.chom.2014.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B65] 65.Luperchio SA, Schauer DB. 2001. Molecular pathogenesis of Citrobacter rodentium and transmissible murine colonic hyperplasia. Microbes Infect 3:333–340. doi: 10.1016/S1286-4579(01)01387-9. [DOI] [PubMed] [Google Scholar]

[B66] 66.Alaniz RC, Thomas SA, Perez-Melgosa M, Mueller K, Farr AG, Palmiter RD, Wilson CB. 1999. Dopamine beta-hydroxylase deficiency impairs cellular immunity. Proc Natl Acad Sci U S A 96:2274–2278. doi: 10.1073/pnas.96.5.2274. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B67] 67.Pacheco AR, Curtis MM, Ritchie JM, Munera D, Waldor MK, Moreira CG, Sperandio V. 2012. Fucose sensing regulates bacterial intestinal colonization. Nature 492:113–117. doi: 10.1038/nature11623. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B68] 68.Kamada N, Kim YG, Sham HP, Vallance BA, Puente JL, Martens EC, Núñez G. 2012. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336:1325–1329. doi: 10.1126/science.1222195. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B69] 69.Willing BP, Vacharaksa A, Croxen M, Thanachayanont T, Finlay BB. 2011. Altering host resistance to infections through microbial transplantation. PLoS One 6:e00826-16. doi: 10.1371/journal.pone.0026988. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B70] 70.Spencer H, Karavolos MH, Bulmer DM, Aldridge P, Chhabra SR, Winzer K, Williams P, Khan CM. 2010. Genome-wide transposon mutagenesis identifies a role for host neuroendocrine stress hormones in regulating the expression of virulence genes in salmonella. J Bacteriol 192:714–724. doi: 10.1128/JB.01329-09. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B71] 71.Hughes DT, Sperandio V. 2008. Inter-kingdom signalling: communication between bacteria and their hosts. Nat Rev Microbiol 6:111–120. doi: 10.1038/nrmicro1836. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B72] 72.Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY. 2015. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:264–276. doi: 10.1016/j.cell.2015.02.047. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B73] 73.Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. 2007. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2:204. doi: 10.1016/j.chom.2007.08.002. [DOI] [PubMed] [Google Scholar]

[B74] 74.Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J, Dougan G, von Mering C, Hardt WD. 2007. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5:2177–2189. doi: 10.1371/journal.pbio.0050244. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B75] 75.Yamamoto K, Hirao K, Oshima T, Aiba H, Utsumi R, Ishihama A. 2005. Functional characterization in vitro of all two-component signal transduction systems from Escherichia coli. J Biol Chem 280:1448–1456. doi: 10.1074/jbc.M410104200. [DOI] [PubMed] [Google Scholar]

[B76] 76.Kendall MM, Gruber CC, Rasko DA, Hughes DT, Sperandio V. 2011. Hfq virulence regulation in enterohemorrhagic Escherichia coli O157:H7 strain 86-24. J Bacteriol 193:6843–6851. doi: 10.1128/JB.06141-11. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B77] 77.Shakhnovich EA, Davis BM, Waldor MK. 2009. Hfq negatively regulates type III secretion in EHEC and several other pathogens. Mol Microbiol 74:347–363. doi: 10.1111/j.1365-2958.2009.06856.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B78] 78.Hansen AM, Kaper JB. 2009. Hfq affects the expression of the LEE pathogenicity island in enterohaemorrhagic Escherichia coli. Mol Microbiol 73:446–465. doi: 10.1111/j.1365-2958.2009.06781.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B79] 79.Schauer DB, Falkow S. 1993. Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect Immun 61:2486–2492. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B80] 80.Sampson TR, Mazmanian SK. 2015. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17:565–576. doi: 10.1016/j.chom.2015.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B81] 81.Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645. doi: 10.1073/pnas.120163297. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B82] 82.Ahmer BM, Thomas MG, Larsen RA, Postle K. 1995. Characterization of the exbBD operon of Escherichia coli and the role of ExbB and ExbD in TonB function and stability. J Bacteriol 177:4742–4747. [DOI] [PMC free article] [PubMed] [Google Scholar]

[B83] 83.Thomas SA, Palmiter RD. 1998. Examining adrenergic roles in development, physiology, and behavior through targeted disruption of the mouse dopamine beta-hydroxylase gene. Adv Pharmacol 42:57–60. [DOI] [PubMed] [Google Scholar]

PERMALINK

Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut

Cristiano G Moreira

Regan Russell

Animesh Anand Mishra

Sanjeev Narayanan

Jennifer M Ritchie

Matthew K Waldor

Meredith M Curtis

Sebastian E Winter

David Weinshenker

Vanessa Sperandio

ABSTRACT

IMPORTANCE

INTRODUCTION

FIG 3 .

RESULTS

The role of QseC and QseE in mammalian infections.

FIG 1 .

FIG 2 .

Epinephrine and norepinephrine regulate virulence gene expression in C. rodentium.

FIG 4 .

Epinephrine and norepinephrine are required for full virulence of C. rodentium during mammalian infection.

FIG 5 .

FIG 6 .

FIG 7 .

TABLE 1 .

DISCUSSION

MATERIALS AND METHODS

Isogenic mutant construction.

In vitro qRT-PCR.

Western blots of secreted proteins.

WT mouse infection experiments.

Dbh−/− knockout mouse assays.

qRT-PCR for gene expression on murine stools.

Histopathology.

EHEC infant rabbit experiments.

SUPPLEMENTAL MATERIAL

ACKNOWLEDGMENTS

Footnotes

REFERENCES

Associated Data

Supplementary Materials

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases

Dbh^−/− knockout mouse assays.